Back to search

Adenosine receptors and their ligands

Data up to Jan 2025

Published2000
Citations324
References27

Total Citations Per Year

Abstract

References (27)

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

1999 • 2,431 citations

Nomenclature and classification of purinoceptors.

1994 • 1,569 citations

The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart1

1929 • 1,470 citations

ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS

1979 • 1,370 citations

Subclasses of external adenosine receptors.

1980 • 1,087 citations

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

1997 • 906 citations

The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

1970 • 860 citations

Adenosine receptors: targets for future drugs

1982 • 681 citations

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

1992 • 649 citations

Molecular cloning and characterization of the human A3 adenosine receptor.

1993 • 421 citations

Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functions

1994 • 395 citations

Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells

1978 • 251 citations

[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.

2000 • 149 citations

Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts

1994 • 140 citations

2-Chloro-N6-[3H]cyclopentyladenosine ([3HCCPA) ?a high affinity agonist radioligand for A1 adenosine receptors

1989 • 131 citations

Water-Soluble Phosphate Prodrugs of 1-Propargyl-8-styrylxanthine Derivatives, A2A-Selective Adenosine Receptor Antagonists

2000 • 119 citations

Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.

1987 • 112 citations

Metabolic flux rates of adenosine in the heart

2000 • 111 citations

Search for New Purine- and Ribose-Modified Adenosine Analogs as Selective Agonists and Antagonists at Adenosine Receptors

1995 • 94 citations

125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.

1995 • 88 citations

New substituted 9-alkylpurines as adenosine receptor ligands

1998 • 78 citations

Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.

1999 • 70 citations

Adenosine A1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonists

1986 • 66 citations

Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]‐SCH 58261

1997 • 63 citations

Comparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling

1991 • 60 citations

Species differences in high‐affinity adenosine A2 binding sites in striatal membranes from mammalian brain

1988 • 60 citations

[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors.

2000 • 59 citations

Cited By (0)

Loading...